Insider · CIK 0001895035
Jason Hsu
Files at IMMX (Immix Biopharma, Inc.). First filing Dec 12, 2023, latest Dec 26, 2024.
In brief
Jason Hsu files SEC Form 4 as director at IMMX (Immix Biopharma, Inc.). Since Dec 12, 2023, Jason Hsu has reported 2 open-market buys worth $371k and 0 open-market sells worth $0, the latest filed on Dec 26, 2024.
A track record needs three past buys with six months of prices behind them; Jason Hsu has 1, so none is measured yet.
The newest scored trade: bought $104k of IMMX on Dec 20, 2024, filed Dec 26, 2024, scored 28 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IMMX: Immix Biopharma, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 28Weak | IMMXbuy Immix Biopharma, Inc. | $104k 47,700 shares | +6% | - | |
| 31Weak | IMMXbuy Immix Biopharma, Inc. | $267k 56,000 shares | +7% | +353% from low-9% from high |
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 22, 2026 | IMMX Immix Biopharma, Inc. | AGrant or award Common Stock | +6,250 | $0.00 | $0 | 899,250 | May 29, 2026 |
| May 22, 2026 | IMMX Immix Biopharma, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +12,500 | $0.00 | $0 | 12,500 | May 29, 2026 |
| Jun 20, 2025 | IMMX Immix Biopharma, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +33,000 | $0.00 | $0 | 33,000 | Jun 23, 2025 |
| Dec 20, 2024 | IMMX Immix Biopharma, Inc. | POpen-market purchase Common Stock | +7,700 | $2.17 | $17k | 853,000 | Dec 26, 2024 |
| Dec 23, 2024 | IMMX Immix Biopharma, Inc. | POpen-market purchase Common Stock | +40,000 | $2.19 | $88k | 893,000 | Dec 26, 2024 |
| Dec 8, 2023 | IMMX Immix Biopharma, Inc. | POpen-market purchase Common Stock | +25,000 | $4.88 | $122k | 782,000 | Dec 12, 2023 |
| Dec 11, 2023 | IMMX Immix Biopharma, Inc. | POpen-market purchase Common Stock | +31,000 | $4.67 | $145k | 813,000 | Dec 12, 2023 |
Questions about Jason Hsu
Answered from the filings on this page, as of the latest one.
Is Jason Hsu buying or selling?
Not in the last 12 months. Jason Hsu's latest open-market trade on SEC Form 4 was bought $104k of IMMX on Dec 20, 2024.
How did Jason Hsu's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jason Hsu has 1.
Where does Jason Hsu file Form 4?
Jason Hsu has filed Form 4 at IMMX (Immix Biopharma, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.